Dudediligence.

Citius Oncology, Inc

CTORNASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Revenue, by quarter
$3.9MDec ’25$1.7MMar ’26$1.5MJun ’26
Net income, by quarter
−$6.8MSep ’24−$6.7MDec ’24−$7.7MMar ’25−$5.4MJun ’25−$5.0MSep ’25−$5.5MDec ’25−$26.6MMar ’26−$8.9MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Sep 2024Sep 2025
Operating incomenone on file−$138,115−$1.0M−$20.6M−$23.5M
Net incomenone on file$380,811$2.4M−$21.1M−$24.8M
Operating cash flownone on file−$47,968−$601,304$126,353−$5.5M
Cashnone on filenone on filenone on file$112.00$3.9M
Shares outstanding2.4M2.4M2.3M71.6M83.5M